Peripheral neuropathy is a nerve disorder with symptoms that include numbness, pain, tingling, and possibly loss of all sensation in the feet. This loss of sensation makes the patient unaware of cuts on the bottom of the feet, which can lead to infection. Approximately 15% of diabetes patients will develop a foot ulcer and need amputation. According to the ADA, diabetic neuropathy is the most common cause of nontraumatic limb amputations worldwide. Beyond drug therapy, there are several developments in peripheral neuropathy treatment that have provided relief to many.
The ADA estimates that 60% of people with diabetes will suffer at least mild neuropathy in their lifetime. To combat this, pain medications are usually prescribed with a reminder to closely monitor blood glucose levels and watch for possible side effects.
One treatment for peripheral neuropathy is Anodyne Therapy. FDA-approved since 1994, this treatment is administered via a machine that emits monochromatic infrared photo energy in order to increase nitric oxide in the blood. It has been clinically proven to increase sensation in the areas affected by neuropathy and decrease pain. It has also been found effective in restoring balance, thus preventing falls, and in treating chronic wounds.
There are 3,600 centers across the U.S. – and additional locations worldwide – where patients can receive this therapy, although a smaller version of the machine can be purchased for long-term, at-home use. Treatment pads are used that produce a warm, soothing sensation. Sometimes there is tingling and pulsing which is a sign that blood flow is being restored. The patient usually has 10-24 therapy sessions but studies have found significant progress within 10-12 treatments. As a result, over 80% of Anodyne Therapy patients have reported excellent to total pain relief. The rate of falling incidents decreased by over 75% and patient activity levels were reported up by over 70%.
So far, it has been determined that there are no side effects if the machine is properly used and monitored. The heating pads can be used on any area of the body and it can be used over any implants because there is no electrical charge. However, women who are pregnant and those with active cancer malignancies must consult their doctor before beginning Anodyne Therapy. The therapy should also not be used directly over heating agents such as Ben Gay, Icy Hot or Capsaicin.
Currently, Anodyne Therapy is covered by Medicare in most areas. Patients with Medicare must first go to a care center for the initial treatment where their progress will be monitored and documented. At that point, insurance may then approve continuing the treatment at home. Patients not using insurance and who wish to purchase the system on their own for use at home can do so at any time.
One in Ten AMI Patients Have Unrecognized Incident Diabetes
Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease
COBA Conference Steers Forward in the Fight Against Childhood Obesity
Google Secures Patent for Glucose-Sensing Contact Lens
Medtronic to Use GlucoSitter Artificial Pancreas Software in Future Insulin Pumps - A Big Deal!
Chili-Glazed Pork Roast Turkey Rollups Crispy Oatmeal Cookies Mushroom Soup Seven Layer Salad Very Cherry Brownies Quick Fruit Dip Low Carb, Low Fat - Apple Cake Tapioca with Mixed Berries Spicy Bean Dip
One of my ongoing dietary issues has been one of protein. Right after diagnosis, I ran a bit scared of all of the "excess protein kills the kidneys" lines and into the old-school health-foods' "you don't need as much protein as you think you do" train of thought. Combined with the calorie and sodium restrictions of my initial diabetes diet, a move away from animal-based proteins because of my cholesterol levels, and a medication which seemed to block nutrient...